0000950170-23-043001.txt : 20230816 0000950170-23-043001.hdr.sgml : 20230816 20230816160124 ACCESSION NUMBER: 0000950170-23-043001 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230101 FILED AS OF DATE: 20230816 DATE AS OF CHANGE: 20230816 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bernard Thierry CENTRAL INDEX KEY: 0001815490 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36571 FILM NUMBER: 231178170 MAIL ADDRESS: STREET 1: 101 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: T2 Biosystems, Inc. CENTRAL INDEX KEY: 0001492674 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 204827488 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 101 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-457-1200 MAIL ADDRESS: STREET 1: 101 HARTWELL AVENUE CITY: LEXINGTON STATE: MA ZIP: 02421 4 1 ownership.xml 4 X0508 4 2023-01-01 0001492674 T2 Biosystems, Inc. TTOO 0001815490 Bernard Thierry 101 HARTWELL AVENUE LEXINGTON MA 02421 true false false false false Common Stock 2023-01-01 4 M false 1550 A 4568 D Common Stock 2023-08-06 4 M false 454 A 5022 D Restricted Stock Units 2023-01-01 4 M false 1550 0 D Common Stock 1550 0 D Restricted Stock Units 2023-08-06 4 M false 454 0 D Common Stock 454 0 D Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. On January 1, 2022 the reporting person was granted 1,550 RSU's that vested in one installment on January 1, 2023. On August 6, 2020 the reporting person was granted 1,363 RSU's that vest in three equal annual installments beginning on August 6, 2021. /s/ Michael Gibbs, Attorney-in-fact 2023-08-16